“…Specific WT1 defects can lead to different phenotypes including (i) WAGR (Wilms–aniridia–genitourinary–mental retardation) syndrome (MIM 194072) due to heterozygous constitutional microdeletions at 11p13 encompassing both WT1 and PAX6 (MIM 607108, coding for a transcription factor controlling the development of eye, nose, central nervous system, and pancreas) (Fantes et al, ); (ii) Denys–Drash syndrome (MIM 194080) with WT, nephropathy, genitourinary abnormalities (males) due to specific missense WT1 mutations (Pelletier et al, ); and (iii) Frasier syndrome (MIM 136680) which is nephropathy with gonadal dysgenesis and gonadoblastoma due to mutations in intron 9 that alter WT1 splicing (Barbaux et al, ). WT also occurs in the context of rare conditions such as Bloom syndrome (Moreira et al, ), mosaic variegated aneuploidy syndrome ( BUB1B ) (Akasaka et al, ), Fanconi anemia ( BRCA2 , PALB2 ) (Reid et al, ; Serra et al, ), Beckwith–Wiedemann syndrome (Mussa et al, ), Perlman syndrome ( DIS3L2 ; coding for exoribonuclease degrading RNAs with 3′‐end poly‐uridylation; MIM 614184) (Astuti et al, ), Simpson–Golabi–Behmel syndrome (Neri, Gurrieri, Zanni, & Lin, ), Li–Fraumeni syndrome (Schlegelberger et al, ), Bohring–Opitz syndrome ( ASXL1 ; the gene product is a Polycomb group member involved in transcriptional regulation; MIM 612990) (Russell et al, ), mulibrey (muscle–liver–brain–eye) nanism ( TRIM37 ; coding for E3 ubiquitin‐protein ligase; MIM 253250) (Avela et al, ), and GLOW (Global developmental delay, Lung cysts, Overgrowth, and WT) syndrome ( DICER1 mosaic) (Klein et al, ). In addition, patients with isolated hemihyperplasia (MIM 235000) have an increased WT risk (Dempsey‐Robertson, Wilkes, Stall, & Bush, ; Hoyme et al, ; Lapunzina, ).…”